According to the 15-minute chart for Orthofix Medical, the Moving Average Convergence Divergence (MACD) indicator has triggered a Death Cross signal, while the Bollinger Bands are currently narrowing. This suggests that the stock price has the potential to continue falling, and the magnitude of the stock price fluctuations is decreasing.
Orthofix Medical Inc. (NASDAQ: OFIX) has received a boost from analyst Michael Petusky of Barrington, who raised the firm's price target to $17 from $16. This comes after the company reported robust fiscal Q2 2025 results, affirming its 2025 outlook and maintaining an Outperform rating [1].
The company's net sales for the quarter reached $203.1 million, showing a 2% growth on a reported basis and 4% on a pro forma constant currency basis compared to Q2 2024. U.S. Spine Fixation and Bone Growth Therapies segments reported net sales growth of 5% and 6% respectively, highlighting strong performance across key business segments.
However, technical indicators suggest a potential downward trend. According to the 15-minute chart for Orthofix Medical, the Moving Average Convergence Divergence (MACD) indicator has triggered a Death Cross signal, while the Bollinger Bands are currently narrowing. This indicates that the stock price may continue to fall, with decreasing magnitude of fluctuations [2].
Despite the positive earnings report, some analysts suggest that certain AI stocks might offer greater upside potential with less downside risk. Investors should consider these factors when making investment decisions.
References:
[1] https://finance.yahoo.com/news/barrington-lifts-pt-orthofix-medical-160844842.html
[2] (Technical analysis based on provided chart data)
Comments
No comments yet